Once-monthly risedronate for postmenopausal osteoporosis

Bisphosphonates are the mainstay of treatment for postmenopausal women with osteoporosis. Despite numerous clinical trials documenting efficacy, tolerability, and safety of bisphosphonate therapy, long-term persistence and adherence to these agents remains low. This has serious consequences for pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Casadei, Kristina, Becker, Carolyn
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2971711/
https://www.ncbi.nlm.nih.gov/pubmed/21072270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2971711/
https://www.ncbi.nlm.nih.gov/pubmed/21072270

Ejemplares similares